PATENT CLAIM ANALYSIS

Application Number: 15910505
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "516000"]

Abstract:
The present invention is directed to methods of treating, preventing, suppressing and/or inhibiting urological disorders such as urinary incontinence including stress urinary incontinence, urge urinary incontinence, mixed incontinence, and pelvic floor disorders by administering a SARM compound of the invention.

Claim (Index 11):
The method according to  claim 4 , wherein the duration of response following completion of the treatment is at least seven months post-treatment.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.35294
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15190732', '15786811', '15887076', '14168993', '13627900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942671491727545
- 35 USC 102 Novelty (BERT): 0.5316074781528177
- Combined Prediction Score: 0.7680011820707608
- Mean Citation Score: 330.533362
- Max Citation Score: 343.53824
- Similarity Product: 189.73816852146143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test